Page last updated: 2024-08-23

sufentanil and Hepatocellular Carcinoma

sufentanil has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, ZY; Gao, YP; Guo, JG; Guo, XJ; Lu, XY; Rao, YF; Sun, JH; Zhao, LP; Zhou, TY1

Other Studies

1 other study(ies) available for sufentanil and Hepatocellular Carcinoma

ArticleYear
Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2018, Volume: 17, Issue:6

    Topics: Adult; Aged; Analgesia, Patient-Controlled; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Isoxazoles; Liver Neoplasms; Male; Middle Aged; Pain, Postoperative; Patient Satisfaction; Postoperative Nausea and Vomiting; Sufentanil

2018